Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)

NCT04915404 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Recurrent Glioblastoma Multiforme

Interventions

DRUG: Berubicin Hydrochloride

Sponsor

WPD Pharmaceuticals Sp. z o.o.

Collaborators

[object Object]
[object Object]